Related Experiment Video
Updated: Aug 16, 2026

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
Sexual dysfunction in males with chronic hepatitis C and antiviral therapy: interferon-induced functional androgen
M R Kraus1, A Schäfer, T Bentink
1Department of Gastroenterology and Hepatology, Medizinische Poliklinik, University of Würzburg, Klinikstrasse 6-8, D-97070 Würzburg, Germany. kraus_m@klinik.uni-wuerzburg.de
Abstract:
Decrease of libido and erectile dysfunction are reported by male patients during antiviral therapy of chronic hepatitis C, but therapy-associated underlying factors for sexual dysfunction are not well defined. To assess putative contributions of interferon-induced sex hormone changes to sexual dysfunction, we prospectively investigated changes in free testosterone, total testosterone, dehydroepiandrosterone sulfate, prolactin, sex hormone-binding globulin, FSH and LH levels and psychometric self-assessment scores in 34 male patients treated with interferon alfa-2b (5 MIU three times weekly) (n=19)+ ribavirin (n=15) for 6-12 months. Depression was measured by the Hospital Anxiety and Depression Scale. Sexual dysfunction was evaluated by the Symptom Checklist 90 Item Revised and a five-point rating scale assessing sexual arousal disorder. Free and total testosterone decreased significantly during antiviral therapy in close correlation with libido/sexual function. Depression scores increased during therapy and were also significantly associated with sexual dysfunction. However, androgen levels displayed no significant correlation with depression. These results suggest that interferon-induced decrease in sexual function is associated - but not causally related -with both androgen reduction and increased depressive symptoms. These findings may affect care for male hepatitis C patients during interferon therapy.
Insights
Antiviral therapy for hepatitis C can decrease male libido and cause erectile dysfunction. This study links these issues to reduced testosterone and increased depression during treatment.
Area of Science:
- Hepatology
- Endocrinology
- Psychiatry
Background:
- Hepatitis C antiviral therapy can cause sexual dysfunction in men.
- Underlying factors contributing to sexual dysfunction during treatment are not well understood.
Purpose of the Study:
- To investigate the impact of interferon-based antiviral therapy on male sexual function.
- To assess the relationship between sex hormone levels, depression, and sexual dysfunction in patients with chronic hepatitis C.
Main Methods:
- Prospective study of 34 male patients undergoing interferon alfa-2b and ribavirin therapy.
- Monitored changes in free and total testosterone, dehydroepiandrosterone sulfate, prolactin, sex hormone-binding globulin, FSH, and LH.
- Assessed depression using the Hospital Anxiety and Depression Scale and sexual dysfunction via Symptom Checklist 90 Item Revised and a sexual arousal disorder scale.
Main Results:
- Significant decreases in free and total testosterone levels were observed during therapy, correlating with reduced libido and sexual function.
- Increased depression scores were associated with sexual dysfunction.
- No significant correlation was found between androgen levels and depression.
Conclusions:
- Hepatitis C antiviral therapy is associated with decreased sexual function in men.
- This decrease is linked to both reduced androgen levels and increased depressive symptoms.
- Findings suggest a multifactorial cause for sexual dysfunction during treatment, impacting patient care.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Infertility in Males
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Hepatitis
Amebiasis
Cirrhosis I: Introduction

